195 related articles for article (PubMed ID: 30350576)
1. Tuning Pharmacokinetics to Improve Tumor Accumulation of a Prostate-Specific Membrane Antigen-Targeted Phototheranostic Agent.
Harmatys KM; Overchuk M; Chen J; Ding L; Chen Y; Pomper MG; Zheng G
Bioconjug Chem; 2018 Nov; 29(11):3746-3756. PubMed ID: 30350576
[TBL] [Abstract][Full Text] [Related]
2. Long-Circulating Prostate-Specific Membrane Antigen-Targeted NIR Phototheranostic Agent.
Overchuk M; Damen MPF; Harmatys KM; Pomper MG; Chen J; Zheng G
Photochem Photobiol; 2020 May; 96(3):718-724. PubMed ID: 31742696
[TBL] [Abstract][Full Text] [Related]
3. The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents.
Mukai H; Wada Y; Watanabe Y
Ann Nucl Med; 2013 Aug; 27(7):625-39. PubMed ID: 23605059
[TBL] [Abstract][Full Text] [Related]
4. A PSMA-targeted theranostic agent for photodynamic therapy.
Chen Y; Chatterjee S; Lisok A; Minn I; Pullambhatla M; Wharram B; Wang Y; Jin J; Bhujwalla ZM; Nimmagadda S; Mease RC; Pomper MG
J Photochem Photobiol B; 2017 Feb; 167():111-116. PubMed ID: 28063300
[TBL] [Abstract][Full Text] [Related]
5. A PEGylation-Free Biomimetic Porphyrin Nanoplatform for Personalized Cancer Theranostics.
Cui L; Lin Q; Jin CS; Jiang W; Huang H; Ding L; Muhanna N; Irish JC; Wang F; Chen J; Zheng G
ACS Nano; 2015; 9(4):4484-95. PubMed ID: 25830219
[TBL] [Abstract][Full Text] [Related]
6. Porphyrin-grafted Lipid Microbubbles for the Enhanced Efficacy of Photodynamic Therapy in Prostate Cancer through Ultrasound-controlled
You Y; Liang X; Yin T; Chen M; Qiu C; Gao C; Wang X; Mao Y; Qu E; Dai Z; Zheng R
Theranostics; 2018; 8(6):1665-1677. PubMed ID: 29556348
[TBL] [Abstract][Full Text] [Related]
7. cRGD Peptide-Conjugated Pyropheophorbide-a Photosensitizers for Tumor Targeting in Photodynamic Therapy.
Li W; Tan S; Xing Y; Liu Q; Li S; Chen Q; Yu M; Wang F; Hong Z
Mol Pharm; 2018 Apr; 15(4):1505-1514. PubMed ID: 29502410
[TBL] [Abstract][Full Text] [Related]
8. Folic Acid-Conjugated Pyropheophorbide a as the Photosensitizer Tested for In Vivo Targeted Photodynamic Therapy.
Wang J; Liu Q; Zhang Y; Shi H; Liu H; Guo W; Ma Y; Huang W; Hong Z
J Pharm Sci; 2017 Jun; 106(6):1482-1489. PubMed ID: 28263847
[TBL] [Abstract][Full Text] [Related]
9. Folate-Targeted Polyethylene Glycol-Modified Photosensitizers for Photodynamic Therapy.
Liu Q; Wang J; Li S; Li G; Chen Q; Hong Z
J Pharm Sci; 2019 Jun; 108(6):2102-2111. PubMed ID: 30677421
[TBL] [Abstract][Full Text] [Related]
10. Theranostic PSMA ligands with optimized backbones for intraoperative multimodal imaging and photodynamic therapy of prostate cancer.
Derks YHW; van Lith SAM; Amatdjais-Groenen HIV; Wouters LWM; Kip A; Franssen GM; Laverman P; Löwik DWPM; Heskamp S; Rijpkema M
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2425-2435. PubMed ID: 35029739
[TBL] [Abstract][Full Text] [Related]
11. Redox-responsive dextran based theranostic nanoparticles for near-infrared/magnetic resonance imaging and magnetically targeted photodynamic therapy.
Ding Z; Liu P; Hu D; Sheng Z; Yi H; Gao G; Wu Y; Zhang P; Ling S; Cai L
Biomater Sci; 2017 Mar; 5(4):762-771. PubMed ID: 28256661
[TBL] [Abstract][Full Text] [Related]
12. N-(2-hydroxypropyl)methacrylamide polymer conjugated pyropheophorbide-a, a promising tumor-targeted theranostic probe for photodynamic therapy and imaging.
Fang J; Šubr V; Islam W; Hackbarth S; Islam R; Etrych T; Ulbrich K; Maeda H
Eur J Pharm Biopharm; 2018 Sep; 130():165-176. PubMed ID: 29885851
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors.
Lütje S; Heskamp S; Franssen GM; Frielink C; Kip A; Hekman M; Fracasso G; Colombatti M; Herrmann K; Boerman OC; Gotthardt M; Rijpkema M
Theranostics; 2019; 9(10):2924-2938. PubMed ID: 31244933
[No Abstract] [Full Text] [Related]
14. Virus-Based Cancer Therapeutics for Targeted Photodynamic Therapy.
Cao B; Xu H; Yang M; Mao C
Methods Mol Biol; 2018; 1776():643-652. PubMed ID: 29869271
[TBL] [Abstract][Full Text] [Related]
15. Photosensitizer loaded nano-graphene for multimodality imaging guided tumor photodynamic therapy.
Rong P; Yang K; Srivastan A; Kiesewetter DO; Yue X; Wang F; Nie L; Bhirde A; Wang Z; Liu Z; Niu G; Wang W; Chen X
Theranostics; 2014; 4(3):229-39. PubMed ID: 24505232
[TBL] [Abstract][Full Text] [Related]
16. Cancer cell membrane-coated magnetic nanoparticles for MR/NIR fluorescence dual-modal imaging and photodynamic therapy.
Li J; Wang X; Zheng D; Lin X; Wei Z; Zhang D; Li Z; Zhang Y; Wu M; Liu X
Biomater Sci; 2018 Jun; 6(7):1834-1845. PubMed ID: 29786715
[TBL] [Abstract][Full Text] [Related]
17. Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.
Chen B; Pogue BW; Zhou X; O'Hara JA; Solban N; Demidenko E; Hoopes PJ; Hasan T
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):720-7. PubMed ID: 15701861
[TBL] [Abstract][Full Text] [Related]
18. Polyacrylamide-based biocompatible Nanoplatform enhances the tumor uptake, PET/fluorescence imaging and anticancer activity of a chlorophyll analog.
Gupta A; Wang S; Marko A; Joshi P; Ethirajan M; Chen Y; Yao R; Sajjad M; Kopelman R; Pandey RK
Theranostics; 2014; 4(6):614-28. PubMed ID: 24723983
[TBL] [Abstract][Full Text] [Related]
19. Porphyrins and related macrocycles: Combining photosensitization with radio- or optical-imaging for next generation theranostic agents.
Sandland J; Malatesti N; Boyle R
Photodiagnosis Photodyn Ther; 2018 Sep; 23():281-294. PubMed ID: 30009949
[TBL] [Abstract][Full Text] [Related]
20. The role of porphyrin chemistry in tumor imaging and photodynamic therapy.
Ethirajan M; Chen Y; Joshi P; Pandey RK
Chem Soc Rev; 2011 Jan; 40(1):340-62. PubMed ID: 20694259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
